BVS Bioventus
- 3.965
- +0.005+0.13%
Bioventus News
Corevist Announces Eight Manufacturers as Winners of the 2024 Golden Bull Awards for Excellence in B2B Ecommerce
DURHAM, N.C., May 3, 2024 /PRNewswire/ -- Corevist, the B2B ecommerce platform that powers customer-central digital channels, today announced the winners of the inaugural Golden Bull Awards, which re
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (NASDAQ:BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today announced that it will report financial results for
Form 144 | Bioventus(BVS.US) Officer Proposes to Sell 197.98K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 11, $Bioventus(BVS.US)$ Officer Singleton Mark Leonard intends to sell 38,000 shares of its common stock on Apr 11, with a total market value of approximately $197.98K. S
Form 144 | Bioventus(BVS.US) Officer Proposes to Sell 140.67K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 11, $Bioventus(BVS.US)$ Officer D'Adamio Anthony intends to sell 27,000 shares of its common stock on Apr 11, with a total market value of approximately $140.67K. D'Adami
Form 144 | Bioventus(BVS.US) Officer Proposes to Sell 281.96K in Common Stocks
SEC FILLINGS DISCLOSED/ Mar 27, $Bioventus(BVS.US)$ Officer Bihl Anthony P III intends to sell 56,392 shares of its common stock on Mar 27, with a total market value of approximately $281.96K. Bihl
Bioventus(BVS.US) Officer Sells US$29,852.69 in Common Stocks
$Bioventus(BVS.US)$ Officer Singleton Mark Leonard sold 5,541 shares of Common Stocks on Mar 22, 2024 at an average price of $5.3876 for a total value of $29,852.69.Source: Announcement What is statem
Form 144 | Bioventus(BVS.US) Officer Proposes to Sell 292.5K in Common Stocks
SEC FILLINGS DISCLOSED/ Mar 25, $Bioventus(BVS.US)$ Officer Bihl Anthony P III intends to sell 57,245 shares of its common stock on Mar 25, with a total market value of approximately $292.5K. Sourc
Bioventus(BVS.US) Officer Sells US$17,062.5 in Common Stocks
$Bioventus(BVS.US)$ Officer D'Adamio Anthony sold 3,125 shares of Common Stocks on Mar 15, 2024 at an average price of $5.46 for a total value of $17,062.5.Source: Announcement What is statement of ch
Bioventus(BVS.US) Officer Sells US$6,644.82 in Common Stocks
$Bioventus(BVS.US)$ Officer CHURCH KATRINA J sold 1,217 shares of Common Stocks on Mar 15, 2024 at an average price of $5.46 for a total value of $6,644.82.Source: Announcement What is statement of ch
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday. Shares of Blend Labs, Inc. (NASDAQ:BLND) rose sharply during Friday's session after the company reported fourth-q
Bioventus Is Maintained at Buy by Craig-Hallum
Bioventus Is Maintained at Buy by Craig-Hallum
Express News | Craig-Hallum Maintains Buy on Bioventus, Raises Price Target to $9
Bioventus Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/13/2024 57.89% Craig-Hallum $6 → $9 Maintains Buy 12/07/2023 22.81% Canaccord Genuity $3.66 → $7 Upgrad
Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Bioventus (BVS) and Pliant Therapeutics (PLRX)
Q4 2023 Bioventus Inc Earnings Call
Earnings Call Summary | Bioventus(BVS.US) Q4 2023 Earnings Conference
The following is a summary of the Bioventus Inc. (BVS) Q4 2023 Earnings Call Transcript:Financial Performance:Bioventus reported Q4 revenue of $135 million, an 8% increase from the previous year.Adjus
Bioventus Reports Upbeat Earnings, Joins Ranpak, Beachbody And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index surging more than 200 points on Tuesday. Shares of Bioventus Inc. (NASDAQ:BVS) rose sharply during Tuesday's session after the company reported bette
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersRegulus Therapeutics (NASDAQ:RGLS) stock moved upwards by 84.8% to $2.55 during Tuesday's pre-market session. The company's market cap stands at $51.5 million. Assure Hldgs (NASDAQ:IONM) stock
Express News | Bioventus Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results and Issued FY24 Net Sales Guidance Above Estimates
Analysis
Price Target
No Data
